ST. HELIER, Jersey (AP) — ST. HELIER, Jersey (AP) — NovoCure Ltd. (NVCR) on Thursday reported a loss of $34.3 million in its first quarter.
On a per-share basis, the St. Helier, Jersey-based company said it had a loss of 31 cents.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.
The oncology drug developer posted revenue of $155 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $147.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVCR at https://www.zacks.com/ap/NVCR
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
